» Articles » PMID: 21600867

Diagnostic Challenges of Nonalcoholic Fatty Liver Disease (NAFLD) in Children of Normal Weight

Overview
Specialty Gastroenterology
Date 2011 May 24
PMID 21600867
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nonalcoholic fatty liver disease (NAFLD) is generally regarded as affecting the overweight or obese. Though previously reported, the notion that NAFLD occurs in the presence of normal body weight (adult BMI<25) is unfamiliar in adults and problematic in children. Normal-body-weight NAFLD accounts for approximately 15% of all NAFLD and may be more prevalent with certain ethnicities.

Case: We describe a case of a child who appeared to have normal-body-weight NAFLD, on the basis of typical age of presentation, ultrasonographically evident hepatic steatosis and compatible liver histology, including a NAFLD activity score of 7, but was shown conclusively to have cystic fibrosis. Further we present a clinical strategy for diagnosis of childhood NAFLD, which would discriminate between this patient and actual normal-body-weight NAFLD children in our clinical practice.

Conclusion: NAFLD requires affirmative diagnostic criteria and should not be merely a diagnosis of exclusion.

Citing Articles

Emerging role of nanotechnology in treatment of non-alcoholic fatty liver disease (NAFLD).

Moghtadaie A, Mahboobi H, Fatemizadeh S, Kamal M EXCLI J. 2023; 22:946-974.

PMID: 38023570 PMC: 10630531. DOI: 10.17179/excli2023-6420.


Prevalence of non-alcoholic fatty liver disease in overweight and obese children seeking ambulatory healthcare in Nairobi, Kenya.

Mburu A, Laving A, Macharia W, Sande J BMJ Open Gastroenterol. 2023; 10(1).

PMID: 36796875 PMC: 9936283. DOI: 10.1136/bmjgast-2022-001044.


Prevalence and Correlates of Suspected Nonalcoholic Fatty Liver Disease in Chinese Children.

Song P, Yu J, Wang M, Chang X, Wang J, An L Int J Environ Res Public Health. 2017; 14(5).

PMID: 28448433 PMC: 5451916. DOI: 10.3390/ijerph14050465.


Multidisciplinary pharmacotherapeutic options for nonalcoholic Fatty liver disease.

Nakajima K Int J Hepatol. 2013; 2012:950693.

PMID: 23304532 PMC: 3523542. DOI: 10.1155/2012/950693.